| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6060327 | Sleep Medicine | 2015 | 7 Pages |
Abstract
Changes in the level of PER2 gene expression can serve as a biomarker of disrupted circadian rhythm in blood cells. Therefore, they can be a useful intermediate indicator of efficacy in future MSC-mediated chemoprevention studies.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ming Zhu Fang, Pamela Ohman-Strickland, Kathie Kelly-McNeil, Howard Kipen, Benjamin F. Crabtree, Jenny Pan Lew, Helmut Zarbl,